Mirum Pharmaceuticals’ MIRM revenue base is largely supported by its lead product, Livmarli (maralixibat), which has been witnessing steady sales uptake since its launch. The drug remains a key

Shares of CME Group Inc. CME have gained 15.5% in the past year, outperforming the industry's growth of 8.1%. CME Group has outperformed its peers, including Intercontinental Exchange Inc. ICE, S&P

An updated edition of the October 28, 2025, article.

The global oncology market is entering a period of significant evolution, supported by rising cancer incidence and rapid scientific advancement

CleanSpark, Inc. CLSK is a leading U.S. Bitcoin miner and data-center operator that is expanding beyond crypto mining into high-performance computing (HPC) and artificial intelligence (AI)

Shares of Cboe Global Markets, Inc. CBOE have gained 30.2% in the past year, outperforming the industry's growth of 8.6%, the Finance sector’s return of 18.1% and the Zacks S&P 500 composite’s

InsurTechs — technology-led insurers — are trying hard to be game changers, leveraging technologies like AI, telematics, data-driven underwriting and machine learning, among others. Yet, Lemonade

Block’s XYZ merchant-facing business, Square, has expanded its partnership with, Thrive, a leading inventory management reporting system. This partnership helps Square sellers easily sync catalogs

Solid state EV battery innovator QuantumScape Corp. QS has again checked off one of its most important goals for 2025— expanding commercial engagement with customers and partners.

The company

Momentum investing is about following stocks that are already doing well, and retaining them as long as the trend remains strong. While some investors worry that momentum means “buying too late,”